APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Contract Development and Manufacturing Organization

A pharmaceutical CDMO provides contracted drug-development and manufacturing services, including process development, analytical work and production of drug substances or finished dosage forms.

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pharmaceutical Contract Development and Manufacturing Organization Industry Growth and Trends Forecast to 2032

Report ID 17421425011 January 2026110 pages

Choose your research edition.

Industry ResearchPharmaceutical Contract Development and Manufacturing Organization Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Contract Development and Manufacturing Organization Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Contract Development and Manufacturing Organization Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Contract Development and Manufacturing Organization Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Contract Development and Manufacturing Organization Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

According to APO Research, the global Pharmaceutical Contract Development and Manufacturing Organization market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pharmaceutical Contract Development and Manufacturing Organization is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical Contract Development and Manufacturing Organization is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical Contract Development and Manufacturing Organization is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Pharmaceutical Contract Development and Manufacturing Organization market include Catalent, Recipharm, Jubilant Life Sciences, Patheon Inc., Boehringer Ingelheim, Pfizer Centreone, Aenova Group, Famar and Baxter Pharmaceutical Solutions, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pharmaceutical Contract Development and Manufacturing Organization market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pharmaceutical Contract Development and Manufacturing Organization market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pharmaceutical Contract Development and Manufacturing Organization market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pharmaceutical Contract Development and Manufacturing Organization.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Pharmaceutical Contract Development and Manufacturing Organization market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pharmaceutical Contract Development and Manufacturing Organization Market by Company

Catalent

Recipharm

Jubilant Life Sciences

Patheon Inc.

Boehringer Ingelheim

Pfizer Centreone

Aenova Group

Famar

Baxter Pharmaceutical Solutions

Lonza Group

Tesa Labtec

Tapemark

ARX LLC

Cambrex

Samsung Biologics

Fujifilm Diosynth Biotechnologies

WuXi Biologics

Center for Breakthrough Medicines (CBM)

Siegfried AG

Pharmaceutical Contract Development and Manufacturing Organization Segment by Type

API Development

Pharmaceutical Manufacturing

Pharmaceutical Contract Development and Manufacturing Organization Segment by Application

Large Enterprise

SME

Pharmaceutical Contract Development and Manufacturing Organization Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Contract Development and Manufacturing Organization market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Contract Development and Manufacturing Organization and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Contract Development and Manufacturing Organization.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Pharmaceutical Contract Development and Manufacturing Organization companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region (2021-2026) Table 4. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region (2027-2032) Table 6. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Share by Type (2021-2026) Table 9. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Share Forecasted by Type (2027-2032) Table 11. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Share by Application (2021-2026) Table 24. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Share Forecasted by Application (2027-2032) Table 26. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Pharmaceutical Contract Development and Manufacturing Organization Industry Trends Table 37. Pharmaceutical Contract Development and Manufacturing Organization Industry Drivers Table 38. Pharmaceutical Contract Development and Manufacturing Organization Industry Opportunities and Challenges Table 39. Pharmaceutical Contract Development and Manufacturing Organization Industry Restraints Table 40. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Company (2021-2026) Table 42. Global Pharmaceutical Contract Development and Manufacturing Organization Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Pharmaceutical Contract Development and Manufacturing Organization Key Company Headquarters & Area Served Table 44. Global Pharmaceutical Contract Development and Manufacturing Organization Company, Product Type & Application Table 45. Global Pharmaceutical Contract Development and Manufacturing Organization Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Pharmaceutical Contract Development and Manufacturing Organization by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Catalent Company Information Table 49. Catalent Business Overview Table 50. Catalent Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Catalent Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 52. Catalent Recent Development Table 53. Recipharm Company Information Table 54. Recipharm Business Overview Table 55. Recipharm Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Recipharm Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 57. Recipharm Recent Development Table 58. Jubilant Life Sciences Company Information Table 59. Jubilant Life Sciences Business Overview Table 60. Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 62. Jubilant Life Sciences Recent Development Table 63. Patheon Inc. Company Information Table 64. Patheon Inc. Business Overview Table 65. Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 67. Patheon Inc. Recent Development Table 68. Boehringer Ingelheim Company Information Table 69. Boehringer Ingelheim Business Overview Table 70. Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 72. Boehringer Ingelheim Recent Development Table 73. Pfizer Centreone Company Information Table 74. Pfizer Centreone Business Overview Table 75. Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 77. Pfizer Centreone Recent Development Table 78. Aenova Group Company Information Table 79. Aenova Group Business Overview Table 80. Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 82. Aenova Group Recent Development Table 83. Famar Company Information Table 84. Famar Business Overview Table 85. Famar Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Famar Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 87. Famar Recent Development Table 88. Baxter Pharmaceutical Solutions Company Information Table 89. Baxter Pharmaceutical Solutions Business Overview Table 90. Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 92. Baxter Pharmaceutical Solutions Recent Development Table 93. Lonza Group Company Information Table 94. Lonza Group Business Overview Table 95. Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 97. Lonza Group Recent Development Table 98. Tesa Labtec Company Information Table 99. Tesa Labtec Business Overview Table 100. Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 102. Tesa Labtec Recent Development Table 103. Tapemark Company Information Table 104. Tapemark Business Overview Table 105. Tapemark Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Tapemark Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 107. Tapemark Recent Development Table 108. ARX LLC Company Information Table 109. ARX LLC Business Overview Table 110. ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 112. ARX LLC Recent Development Table 113. Cambrex Company Information Table 114. Cambrex Business Overview Table 115. Cambrex Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Cambrex Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 117. Cambrex Recent Development Table 118. Samsung Biologics Company Information Table 119. Samsung Biologics Business Overview Table 120. Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 122. Samsung Biologics Recent Development Table 123. Fujifilm Diosynth Biotechnologies Company Information Table 124. Fujifilm Diosynth Biotechnologies Business Overview Table 125. Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 127. Fujifilm Diosynth Biotechnologies Recent Development Table 128. WuXi Biologics Company Information Table 129. WuXi Biologics Business Overview Table 130. WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 132. WuXi Biologics Recent Development Table 133. Center for Breakthrough Medicines (CBM) Company Information Table 134. Center for Breakthrough Medicines (CBM) Business Overview Table 135. Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 137. Center for Breakthrough Medicines (CBM) Recent Development Table 138. Siegfried AG Company Information Table 139. Siegfried AG Business Overview Table 140. Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio Table 142. Siegfried AG Recent Development Table 143. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2026) Table 146. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Pharmaceutical Contract Development and Manufacturing Organization Market Share Forecast by Country (2027-2032) Table 148. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2026) Table 151. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2026) Table 156. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Share Forecast by Country (2027-2032) Table 158. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2026) Table 161. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Share Forecast by Country (2027-2032) Table 163. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2026) Table 166. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Share Forecast by Country (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Pharmaceutical Contract Development and Manufacturing Organization Product Image Figure 3. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size (2021-2032) & (US$ Million) Figure 5. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region: 2025 VS 2032 Figure 6. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region (2021-2032) Figure 7. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. API Development Image Figure 13. Global API Development Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Pharmaceutical Manufacturing Image Figure 15. Global Pharmaceutical Manufacturing Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Type 2025 VS 2032 Figure 18. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Share by Type (2021-2032) Figure 19. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Share by Type (2021-2032) Figure 21. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Share by Type (2021-2032) Figure 23. Large Enterprise Image Figure 24. Global Large Enterprise Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. SME Image Figure 26. Global SME Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Application 2025 VS 2032 Figure 29. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Share by Application (2021-2032) Figure 30. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Share by Application (2021-2032) Figure 32. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Pharmaceutical Contract Development and Manufacturing Organization Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2032) Figure 39. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2032) Figure 42. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2032) Figure 45. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2032) Figure 48. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • API Development
  • Pharmaceutical Manufacturing
Applications
  • Large Enterprise
  • SME
Companies covered
  • Catalent
  • Recipharm
  • Jubilant Life Sciences
  • Patheon Inc.
  • Boehringer Ingelheim
  • Pfizer Centreone
  • Aenova Group
  • Famar
  • Baxter Pharmaceutical Solutions
  • Lonza Group
  • Tesa Labtec
  • Tapemark
  • ARX LLC
  • Cambrex
  • Samsung Biologics
  • Fujifilm Diosynth Biotechnologies
  • WuXi Biologics
  • Center for Breakthrough Medicines (CBM)
  • Siegfried AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2021-2032)
  5. 1.4.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2021-2026)
  6. 1.4.2 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2027-2032)
  7. 1.5 Key Regions Pharmaceutical Contract Development and Manufacturing Organization Market Size (2021-2032)
  8. 1.5.1 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (2021-2032)
2 Pharmaceutical Contract Development and Manufacturing Organization Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 API Development
  3. 2.1.2 Pharmaceutical Manufacturing
  4. 2.2 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Type
  5. 2.2.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Pharmaceutical Contract Development and Manufacturing Organization Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Regions
  9. 2.3.1 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Type (2021-2026)
3 Pharmaceutical Contract Development and Manufacturing Organization Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Large Enterprise
  3. 3.1.2 SME
  4. 3.2 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Application
  5. 3.2.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Pharmaceutical Contract Development and Manufacturing Organization Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Regions
  9. 3.3.1 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Pharmaceutical Contract Development and Manufacturing Organization Industry Trends
  2. 4.2 Pharmaceutical Contract Development and Manufacturing Organization Industry Drivers
  3. 4.3 Pharmaceutical Contract Development and Manufacturing Organization Industry Opportunities and Challenges
  4. 4.4 Pharmaceutical Contract Development and Manufacturing Organization Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Pharmaceutical Contract Development and Manufacturing Organization Revenue (2021-2026)
  2. 5.2 Global Pharmaceutical Contract Development and Manufacturing Organization Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Pharmaceutical Contract Development and Manufacturing Organization Key Company Headquarters & Area Served
  4. 5.4 Global Pharmaceutical Contract Development and Manufacturing Organization Company, Product Type & Application
  5. 5.5 Global Pharmaceutical Contract Development and Manufacturing Organization Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Pharmaceutical Contract Development and Manufacturing Organization Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Pharmaceutical Contract Development and Manufacturing Organization Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Catalent
  2. 6.1.1 Catalent Company Information
  3. 6.1.2 Catalent Business Overview
  4. 6.1.3 Catalent Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Catalent Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  6. 6.1.5 Catalent Recent Developments
  7. 6.2 Recipharm
  8. 6.2.1 Recipharm Company Information
  9. 6.2.2 Recipharm Business Overview
  10. 6.2.3 Recipharm Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Recipharm Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  12. 6.2.5 Recipharm Recent Developments
  13. 6.3 Jubilant Life Sciences
  14. 6.3.1 Jubilant Life Sciences Company Information
  15. 6.3.2 Jubilant Life Sciences Business Overview
  16. 6.3.3 Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  18. 6.3.5 Jubilant Life Sciences Recent Developments
  19. 6.4 Patheon Inc.
  20. 6.4.1 Patheon Inc. Company Information
  21. 6.4.2 Patheon Inc. Business Overview
  22. 6.4.3 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  24. 6.4.5 Patheon Inc. Recent Developments
  25. 6.5 Boehringer Ingelheim
  26. 6.5.1 Boehringer Ingelheim Company Information
  27. 6.5.2 Boehringer Ingelheim Business Overview
  28. 6.5.3 Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  30. 6.5.5 Boehringer Ingelheim Recent Developments
  31. 6.6 Pfizer Centreone
  32. 6.6.1 Pfizer Centreone Company Information
  33. 6.6.2 Pfizer Centreone Business Overview
  34. 6.6.3 Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  36. 6.6.5 Pfizer Centreone Recent Developments
  37. 6.7 Aenova Group
  38. 6.7.1 Aenova Group Company Information
  39. 6.7.2 Aenova Group Business Overview
  40. 6.7.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  42. 6.7.5 Aenova Group Recent Developments
  43. 6.8 Famar
  44. 6.8.1 Famar Company Information
  45. 6.8.2 Famar Business Overview
  46. 6.8.3 Famar Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Famar Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  48. 6.8.5 Famar Recent Developments
  49. 6.9 Baxter Pharmaceutical Solutions
  50. 6.9.1 Baxter Pharmaceutical Solutions Company Information
  51. 6.9.2 Baxter Pharmaceutical Solutions Business Overview
  52. 6.9.3 Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  54. 6.9.5 Baxter Pharmaceutical Solutions Recent Developments
  55. 6.10 Lonza Group
  56. 6.10.1 Lonza Group Company Information
  57. 6.10.2 Lonza Group Business Overview
  58. 6.10.3 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  60. 6.10.5 Lonza Group Recent Developments
  61. 6.11 Tesa Labtec
  62. 6.11.1 Tesa Labtec Company Information
  63. 6.11.2 Tesa Labtec Business Overview
  64. 6.11.3 Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  66. 6.11.5 Tesa Labtec Recent Developments
  67. 6.12 Tapemark
  68. 6.12.1 Tapemark Company Information
  69. 6.12.2 Tapemark Business Overview
  70. 6.12.3 Tapemark Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Tapemark Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  72. 6.12.5 Tapemark Recent Developments
  73. 6.13 ARX LLC
  74. 6.13.1 ARX LLC Company Information
  75. 6.13.2 ARX LLC Business Overview
  76. 6.13.3 ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  78. 6.13.5 ARX LLC Recent Developments
  79. 6.14 Cambrex
  80. 6.14.1 Cambrex Company Information
  81. 6.14.2 Cambrex Business Overview
  82. 6.14.3 Cambrex Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Cambrex Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  84. 6.14.5 Cambrex Recent Developments
  85. 6.15 Samsung Biologics
  86. 6.15.1 Samsung Biologics Company Information
  87. 6.15.2 Samsung Biologics Business Overview
  88. 6.15.3 Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  90. 6.15.5 Samsung Biologics Recent Developments
  91. 6.16 Fujifilm Diosynth Biotechnologies
  92. 6.16.1 Fujifilm Diosynth Biotechnologies Company Information
  93. 6.16.2 Fujifilm Diosynth Biotechnologies Business Overview
  94. 6.16.3 Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  96. 6.16.5 Fujifilm Diosynth Biotechnologies Recent Developments
  97. 6.17 WuXi Biologics
  98. 6.17.1 WuXi Biologics Company Information
  99. 6.17.2 WuXi Biologics Business Overview
  100. 6.17.3 WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  102. 6.17.5 WuXi Biologics Recent Developments
  103. 6.18 Center for Breakthrough Medicines (CBM)
  104. 6.18.1 Center for Breakthrough Medicines (CBM) Company Information
  105. 6.18.2 Center for Breakthrough Medicines (CBM) Business Overview
  106. 6.18.3 Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  108. 6.18.5 Center for Breakthrough Medicines (CBM) Recent Developments
  109. 6.19 Siegfried AG
  110. 6.19.1 Siegfried AG Company Information
  111. 6.19.2 Siegfried AG Business Overview
  112. 6.19.3 Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Product Portfolio
  114. 6.19.5 Siegfried AG Recent Developments
7 North America
  1. 7.1 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026)
  3. 7.3 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026)
  3. 8.3 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026)
  3. 10.3 South America Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst